China Pharmaceutical Industry Monthly Market Monitoring Report
A must-have for enterprise medium to long-term strategic planning
Without deep industry knowledge, it will be difficult to gain any return
English Version:USD12500
Including: Paper back + Electronic Copy + Invoice
Customer Hotline:+86 755 - 82925195 / 82925295
Free Hotline:+86 400-068-7188After-sales Hotline: +86 755-33013088
The Ministry of Commerce of the People's Republic of China designated Qianzhan Industrial Research Institute as the only "regional workstation for dealing with trade friction" in the Guangdong-Hong Kong-Macao Greater Bay Area
Customer Hotline:+86 755 - 82925195 / 82925295
Free Hotline:+86 400-068-7188
0755 - 82925195
400-068-7188
We are aware of that the content of our products have been stolen by some ones who changed the design and used it to deceive customers as it is their own products. Customers who are misled may experience no product received or an incomplete product. Therefore, Qianzhan Industrial Research Institute encourage you to arrange an in-person visit to our company before you make the purchase. Qianzhan has the sole copyright of all research reports. We have never had partnership or affiliated with any third party agent. Please recognize the""trademark when purchasing reports.To have better investment return or strategic outcomes, you must have a forward-looking vision. Qianzhan Industrial Research Institute - China's leading industry consulting institutions provide you with all the things you need in business!
* The table of contents and the rest of this report are originally created by Qianzhan. Without any prior written permission, it is prohibited to copy or reproduce in any way. To have better investment return or strategic outcomes, you must have a forward-looking vision!
Table of Contents
Content Summary
The use and value of this report: with a long-term and consecutive dynamically monitoring and analyzing of the first hand market data, Forward continuously provide strategic references for enterprises in a objective perspective. Therefore, it’s helpful for enterprises to fully grasp the latest news of the industry, to study and judge the market competition environment monthly and timely to adjust their management and competition strategies. Meanwhile, the report is very useful for many related investment departments.
In 2012, the State will further enlarge the investment in medical health services, so the pharmaceutical market size is expected to enlarge. The improvement of basic pharmaceutical system, the continuously deepening of new healthcare reform and the implementation of every plans in the “Twelfth Five-year” Plan on Pharmaceutical Industry in succession, as well as the lasting adjustment of medical product price will all deeply affect the pharmaceutical industry in the aspect of structure. In addition, national support on innovation increases, thus pharmaceutical enterprises are expected to develop rapidly in a new round.
The information scope of pharmaceutical industry monthly monitoring report covers the entire pharmaceutical industry; meanwhile, it focuses on medicine market. The eleven core tasks of this report are listed below: firstly, concerning about the latest development trend of international pharmaceutical market; secondly, dynamically monitoring China monthly policy environment, economic environment, trading environment, investment and financing environment, social environment and so on; thirdly, analyzing the monthly macroeconomic operational conditions of pharmaceutical industry and its sub-industries; fourthly, concerning about the monthly up and down stream industries of pharmaceutical industry, intensively focusing on the pharmaceutical raw materials and drug packing materials; fifthly, dynamically monitoring monthly investment trend of pharmaceutical market, including merger and restructuring, capital investment and financing, the trend of foreign investment in China, etc; sixthly, intensively monitoring monthly market competition situation of pharmaceutical industry, including drug price, quality supervision, product recall, etc; seventhly, intensively monitoring and analyzing monthly listing of new drugs and development & progress of medicine study; eighthly, intensively monitoring the monthly marketing mode and channel construction trend of pharmaceutical industry; ninthly, intensively monitoring key investment regions and development trend of domestic pharmaceutical industry; tenthly, intensively analyzing the latest operational and development trends of domestic pharmaceutical enterprises; eleventhly, under the fully monitoring circumstance of monthly massive data, analyzing the hot issues during pharmaceutical industry operation period from different perspectives and in a deep analytical way, and providing some functional management strategies and suggestions for pharmaceutical industry.
The use and value of this report: with a long-term and consecutive dynamically monitoring and analyzing of the first hand market data, Forward continuously provide strategic references for enterprises in a objective perspective. Therefore, it’s helpful for enterprises to fully grasp the latest news of the industry, to study and judge the market competition environment monthly and timely to adjust their management and competition strategies. Meanwhile, the report is very useful for many related investment departments.
Here, we would like to express our sincere gratitude to Bureau of Statistics of China, China Customs, State Information Center and Beijing Essence Forward Research Center, for their great support when we conduct this monthly pharmaceutical report!
Qianzhan Business Information Co., Ltd. Industry Research Center
Monthly Monitoring Research Team of Pharmaceutical Industry
The National Bureau of Statistics Foreign-related investigation Permission
National Innovation Company and Dual Software Certified Enterprise
The only DRC desginated Enterprise of the Industry Yearbook
National Ministry of Commerce designated Industrial Early Warning and Monitoring Workstation
Guangdong Province Enterprise of Observing Contract and Valuing Credit
Qianzhan is an industry consulting service provider with national innovation company qualification, independent research and development of industrial big data and Dual Software Certification.
Qianzhan is a consulting and research organization that has been engaged in business consulting for over 16 years in China.
Qianzhan is a consulting service provider with a team of nearly 300 industrial researchers and analysts.
Qianzhan is a consulting service provider with an in-house expert pool of 1200 experts.
Qianzhan is a research and consulting organization that have served 180000 clients and received over positive comments from 100000 of our clients.
Qianzhan is an industry research and consulting organization that has been designated by the highest authority, the DRC, to prepare the yearbook.
Qianzhan is an industry planning and consulting organization that adopts the internationally synchronized SCP scientific analysis model and the perfect industry chain research map to guide the business planning and consulting.
Qizhan is a consulting service organization that helps enterprises to solve the five aspects of industry research, planning, strategic design, capital operation and implementation.
Free Hotline:+86 400-068-7188
Customer Hotline:+86 755 - 82925195 / 82925295
Email Address:service@qianzhan.com
3rd Floor, FIYTA Building West, High Tech South Avenue 1, Nanshan District, Shenzhen, China
Location:Rm.1106, Building 1, Jiayu International Plaza, Songhu Road, Yangpu District,
Shanghai, China
Quality Assured
Offer a forward-looking vision to all of our customers.
Customer Service
We welcome any feedbacks and suggestions to make our customers 100% satisfied.
Qualification Certificates
Having more than 20 qualification certificates, including Innovation Company Certificate and Foreign-related investigation Permission etc.
Customers Testimonials
Thank you for recognizing our high quality products and professional, rigorous and sincere service.